FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/10/2022
Back to search
Official data from USPTO
EPIGENERON
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
04/10/2022
Trademark type
Combined
Nice classes
1, 9, 42
Filing date
07/05/2019
Registration date
10/05/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/05/2021
Last transaction
10/05/2021
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
JP
Examiner
OSGOOD, KRYSTINA E
Law office
N30
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a geometric figure made by six circles and five straight lines in orange, and four circles and twelve straight lines in grey. The word "EPIGENERON" is in black to the right of the geometric figure. The color white in the mark is background only, and is not claimed as a feature of the mark.
Holders and representatives
Holders
Epigeneron, Inc.
Representatives
SANDRA EPP RYAN HAMRE SCHUMANN MUELLER & LARSON PC
Technical classification
Nice Classes
Class 1Class 9Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical reagents for genetic researchother than for medical or veterinary purposes; chemical reagentsother than for medical or veterinary purposes; reagents for genetic researchother than for medical or veterinary purposes; reagents for research purposes; reagents for scientific purposes for use in nucleic acid isolation and purification; reagents for scientific purposes; chemicals for use in the manufacture of pharmaceuticals; industrial chemicals
Class 9
Genetic specimen samplersother than for medical usenamely testing sample collection equipment in the nature of wipes and swabs for use in diagnostic testingnot for medical purposes; DNA chips; gene testing equipment for research purposesnamely electrical equipment for detection of gene mutations of cells for research purposes; analytical apparatusnamely apparatus for detection of gene mutations of cells for use in laboratory; laboratory kits for use with reagents for genetic research comprised primary of laboratory devices for detecting genetic sequences and laboratory devices for extracting DNA; laboratory apparatus and instruments in the form of kits comprised primary of laboratory devices for detecting genetic sequences and laboratory devices for extracting DNA
Class 42
Testinginspectionresearch or development services in the fields of genegenetic mutation analysis for scientific research purposes and genetic testing for scientific research purposes; consultancy and information services relating to testinginspectionresearch or development services in the fields of genescientific research information and consulting in the field of genetics; scientific research in the fields of genetics and genetic engineering; testinginspectionresearch or development services in the fields of chemistrytesting of chemicals and scientific research and development in the field of chemistry; consultancy and information services relating to testinginspectionresearch or development services in the fields of chemistrychemistry information and consulting; testinginspectionresearch or development services in the fields of pharmaceuticalstestinginspectionresearch or development of pharmaceutical preparations for medical purposes; consultancy and information services relating to testinginspectionresearch or development services in the fields of pharmaceuticalsconsultation and information relating to testinginspectionresearch or development of pharmaceutical preparation for manipulation of gene expression and detection of gene mutations; testinginspectionresearch or development services in the fields of cosmetics or foodstuffsnamely detection of contaminant components in soilwaste and water derived from microbesanimal and plant species; consultancy and information services relating to testinginspectionresearch or development services in the fields of cosmetics or foodstuffsnamely detection of contaminant components in soilwaste and water derived from microbesanimal and plant species; testinginspection or research in the fields of agriculturelivestock breeding or fisheries; scientific laboratory services
Publications
History of USPTO decisions and trademark events.
39 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/17/2022
FIMP
FINAL DISPOSITION PROCESSED
03/17/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/05/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
10/05/2021
TMBN
TTAB RELEASE CASE TO TRADEMARKS
08/30/2021
OP.T
OPPOSITION TERMINATED NO. 999999
08/30/2021
OP.D
OPPOSITION DISMISSED NO. 999999
08/30/2021
RFNP
REFUSAL PROCESSED BY IB
07/18/2021
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
07/09/2021
OP.I
OPPOSITION INSTITUTED NO. 999999
06/24/2021
OPNS
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
06/22/2021
OPNC
OPPOSITION NOTICE (IB REFUSAL) CREATED
06/22/2021
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/10/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/21/2021
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/21/2021
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
01/21/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/22/2020
PUBO
PUBLISHED FOR OPPOSITION
12/22/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/02/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/18/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/28/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/27/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
10/27/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
07/15/2020
GNFR
FINAL REFUSAL E-MAILED
07/15/2020
CNFR
FINAL REFUSAL WRITTEN
07/15/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/19/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/18/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/18/2020
RFNT
REFUSAL PROCESSED BY IB
01/10/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/21/2019
RFRR
REFUSAL PROCESSED BY MPU
12/21/2019
MAFR
APPLICATION FILING RECEIPT MAILED
11/30/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/28/2019
CNRT
NON-FINAL ACTION WRITTEN
11/27/2019
DOCK
ASSIGNED TO EXAMINER
11/26/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/26/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/21/2019
Continuous trademark protection
Get notified about every new filing that threatens EPIGENERON or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.